These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 38862619)
1. Persistent brain metabolic impairment in long COVID patients with persistent clinical symptoms: a nine-month follow-up [ Horowitz T; Dudouet P; Campion JY; Kaphan E; Radulesco T; Gonzalez S; Cammilleri S; Ménard A; Guedj E Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3215-3222. PubMed ID: 38862619 [TBL] [Abstract][Full Text] [Related]
2. Guedj E; Campion JY; Dudouet P; Kaphan E; Bregeon F; Tissot-Dupont H; Guis S; Barthelemy F; Habert P; Ceccaldi M; Million M; Raoult D; Cammilleri S; Eldin C Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2823-2833. PubMed ID: 33501506 [TBL] [Abstract][Full Text] [Related]
3. Visual interpretation of brain hypometabolism related to neurological long COVID: a French multicentric experience. Verger A; Kas A; Dudouet P; Goehringer F; Salmon-Ceron D; Guedj E Eur J Nucl Med Mol Imaging; 2022 Jul; 49(9):3197-3202. PubMed ID: 35320385 [TBL] [Abstract][Full Text] [Related]
4. Guedj E; Million M; Dudouet P; Tissot-Dupont H; Bregeon F; Cammilleri S; Raoult D Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):592-595. PubMed ID: 32728799 [TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of serial Fernando S; Lin M; Pham TT; Chong S; Ip E; Wong K; Chua W; Ng W; Lin P; Lim S Br J Radiol; 2020 Jan; 93(1105):20190455. PubMed ID: 31617737 [TBL] [Abstract][Full Text] [Related]
6. In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. Hutchings M; Kostakoglu L; Zaucha JM; Malkowski B; Biggi A; Danielewicz I; Loft A; Specht L; Lamonica D; Czuczman MS; Nanni C; Zinzani PL; Diehl L; Stern R; Coleman M J Clin Oncol; 2014 Sep; 32(25):2705-11. PubMed ID: 25071108 [TBL] [Abstract][Full Text] [Related]
7. Similar patterns of [ Morand A; Campion JY; Lepine A; Bosdure E; Luciani L; Cammilleri S; Chabrol B; Guedj E Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):913-920. PubMed ID: 34414470 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance of Rubini G; Ferrari C; Altini C; Cimino A; Fanelli M; Niccoli Asabella A Curr Med Imaging Rev; 2019; 15(1):32-38. PubMed ID: 31964325 [TBL] [Abstract][Full Text] [Related]
11. Abnormal brain glucose metabolism patterns in patients with advanced non-small-cell lung cancer after chemotherapy:A retrospective PET study. Yu J; Cao X; Zhou R; Chen Q; Wang Y Brain Res Bull; 2023 Oct; 202():110751. PubMed ID: 37625525 [TBL] [Abstract][Full Text] [Related]
12. Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction. Wieder HA; Ott K; Lordick F; Becker K; Stahl A; Herrmann K; Fink U; Siewert JR; Schwaiger M; Weber WA Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1925-32. PubMed ID: 17680242 [TBL] [Abstract][Full Text] [Related]
13. Do changes in oxygen metabolism in the unaffected cerebral hemisphere underlie early neurological recovery after stroke? A positron emission tomography study. Iglesias S; Marchal G; Rioux P; Beaudouin V; Hauttement AJ; de la Sayette V; Le Doze F; Derlon JM; Viader F; Baron JC Stroke; 1996 Jul; 27(7):1192-9. PubMed ID: 8685927 [TBL] [Abstract][Full Text] [Related]
14. Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer. Giovacchini G; Picchio M; Schipani S; Landoni C; Gianolli L; Bettinardi V; Di Muzio N; Gilardi MC; Fazio F; Messa C Tumori; 2009; 95(2):177-84. PubMed ID: 19579863 [TBL] [Abstract][Full Text] [Related]
15. Interim FDG-PET improves treatment failure prediction in primary central nervous system lymphoma: An LOC network prospective multicentric study. Rozenblum L; Houillier C; Baptiste A; Soussain C; Edeline V; Naggara P; Soret M; Causse-Lemercier V; Willems L; Choquet S; Ursu R; Galanaud D; Belin L; Hoang-Xuan K; Kas A Neuro Oncol; 2024 Jul; 26(7):1292-1301. PubMed ID: 38366824 [TBL] [Abstract][Full Text] [Related]
16. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Sollini M; Morbelli S; Ciccarelli M; Cecconi M; Aghemo A; Morelli P; Chiola S; Gelardi F; Chiti A Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3187-3197. PubMed ID: 33677642 [TBL] [Abstract][Full Text] [Related]
17. Prognostic values of mid-radiotherapy Kim N; Cho H; Yun M; Park KR; Lee CG Radiat Oncol; 2019 Feb; 14(1):27. PubMed ID: 30717809 [TBL] [Abstract][Full Text] [Related]
18. Pre- and per-treatment 18F-FDG PET/CT parameters to predict recurrence and survival in cervical cancer. Leseur J; Roman-Jimenez G; Devillers A; Ospina-Arango JD; Williaume D; Castelli J; Terve P; Lavoue V; Garin E; Lejeune F; Acosta O; De Crevoisier R Radiother Oncol; 2016 Sep; 120(3):512-518. PubMed ID: 27569847 [TBL] [Abstract][Full Text] [Related]
19. Variability of Hepatic 18F-FDG Uptake at Interim PET in Patients With Hodgkin Lymphoma. Rubello D; Gordien P; Morliere C; Guyot M; Bordenave L; Colletti PM; Hindié E Clin Nucl Med; 2015 Aug; 40(8):e405-10. PubMed ID: 26018686 [TBL] [Abstract][Full Text] [Related]
20. The clinical and predictive value of Dai Y; Zhu Z; Tang Y; Xiao L; Liu X; Zhang M; Xiao B; Hu K; Long L; Xie Y; Hu S CNS Neurosci Ther; 2024 Jul; 30(7):e14821. PubMed ID: 38948940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]